Vivet Therapeutics CEO, Jean-Philippe Combal, will be participating to a panel during 2021 World Orphan Drug Congress Europe in Barcelona (Nov 15-18).
The panel is entitled “Improving clinical trial design for rare diseases” (2.10pm / Tuesday November, 16 2021). The participants will discuss the following aspects:
– Tailoring clinical design models to reflect the uniqueness of the gene therapy modality
– Using real world evidence studies to add value throughout the gene therapy development lifecycle
– Managing patient expectations and establishing patient support systems